Debenedetti, ArrigoArrigoDebenedettiBhoir, SiddhantSiddhantBhoirSingh, VibhaVibhaSinghHussain, JaveenaJaveenaHussainChikhale, RupeshRupeshChikhaleBryce, RichardRichardBryceKirubakaran, SivapriyaSivapriyaKirubakaran2025-08-292025-08-292020-03-30https://patentimages.storage.googleapis.com/7d/79/8e/a52378e4f8538e/US11826369.pdfhttps://repository.iitgn.ac.in/handle/IITG2025/20446A method of treating prostate cancer in a patient comprising administering to the patient a pharmaceutical composition including a first therapeutic including a TLK1B inhibitor, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, and a second therapeutic including an antiandrogen or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof.en-USTargeting the TLK1/NEK1 axis in prostate cancerPatents GrantedUS11826369[US16/834,061]123456789/325